Taylor Robichaux/LinkedIn
Jan 9, 2026, 07:07
Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
Taylor Robichaux, Emergency Medicine Clinical Pharmacist at Ochsner LSU Health, shared on LinkedIn:
”The landscape for cTTP is evolving!
Check out our paper on recombinant ADAMTS13 in JADPRO!
It was a privilege to work with such a great group of pharmacists.
Congratulations to all the authors!”
Read the full article here.
Article: Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura
Authors: Taylor Robichaux, Kathryn Dane, Christopher Parish, Justin Arnall, Donald Moore
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH